Literature DB >> 8561044

Transcranial cerebral oximetry and carotid cavernous fistula occlusion. Technical note.

M Dujovny1, K V Slavin, M S Luer, G Hernandez-Avila, J I Ausman.   

Abstract

Different methods have been used in the evaluation and monitoring of the cerebral oxygen supply during neuro-interventional therapies. Attenuation of near-infrared light by the chromophores oxyhemoglobin and deoxyhemoglobin have shown to be useful in the study of the cellular oxygen metabolism and oxygen delivery to the brain. Transcranial cerebral oximetry (TCCO) has the advantage of providing real-time information regarding regional brain oxygen saturation (rSO2) by using wavelengths in the near-infrared range. We present a patient with a carotid cavernous fistula who underwent balloon occlusion and concurrent continuous TCCO monitoring. TCCO was found to be a useful tool providing immediate rSO2 values during the angiographic and interventional procedures. Initial balloon occlusion of a carotid cavernous fistula resulted in partial occlusion of the internal carotid artery lumen causing an immediate decrease in rSO2 which correlated with angiographic findings. Subsequent reocclusion of the fistula produced a slower and smaller degree of decrease in rSO2 with clinical improvement in the patient. Changes in rSO2 were detected before any adverse clinical event was observed. TCCO was reliable, safe, sensitive, and provided a real-time assessment tool for the monitoring of brain oxygen supply in a patient undergoing a neuroendovascular procedure.

Entities:  

Mesh:

Year:  1995        PMID: 8561044     DOI: 10.1007/bf01404954

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  Measurement of regional cerebrovascular haemoglobin oxygen saturation in cats using optical spectroscopy.

Authors:  P W McCormick; M Stewart; P Ray; G Lewis; M Dujovny; J I Ausman
Journal:  Neurol Res       Date:  1991-03       Impact factor: 2.448

2.  Use of cerebral oximetry to monitor brain oxygenation reserves for skull base surgery.

Authors:  M Dujovny; K V Slavin; G Hernandez; G K Geremia; J I Ausman
Journal:  Skull Base Surg       Date:  1994

3.  Inside a quantitative analysis of in vivo near infrared monitoring.

Authors:  F Carta; M Ferrari; I Giannini
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

4.  Reperfusion hyperoxia in brain after circulatory arrest in humans.

Authors:  D S Smith; W Levy; M Maris; B Chance
Journal:  Anesthesiology       Date:  1990-07       Impact factor: 7.892

5.  Optical properties of human brain tissue, meninges, and brain tumors in the spectral range of 200 to 900 nm.

Authors:  H R Eggert; V Blazek
Journal:  Neurosurgery       Date:  1987-10       Impact factor: 4.654

6.  Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation.

Authors:  S Wray; M Cope; D T Delpy; J S Wyatt; E O Reynolds
Journal:  Biochim Biophys Acta       Date:  1988-03-30

7.  Noninvasive cerebral optical spectroscopy for monitoring cerebral oxygen delivery and hemodynamics.

Authors:  P W McCormick; M Stewart; M G Goetting; M Dujovny; G Lewis; J I Ausman
Journal:  Crit Care Med       Date:  1991-01       Impact factor: 7.598

8.  Intracerebral penetration of infrared light. Technical note.

Authors:  P W McCormick; M Stewart; G Lewis; M Dujovny; J I Ausman
Journal:  J Neurosurg       Date:  1992-02       Impact factor: 5.115

9.  Cerebral oxygen metabolism during hypothermic circulatory arrest in humans.

Authors:  J I Ausman; P W McCormick; M Stewart; G Lewis; M Dujovny; G Balakrishnan; G M Malik; R F Ghaly
Journal:  J Neurosurg       Date:  1993-12       Impact factor: 5.115

10.  Effects of carotid compression, as assessed by near infrared spectroscopy, upon cerebral blood volume and hemoglobin oxygen saturation.

Authors:  M Ferrari; E Zanette; G Sideri; I Giannini; C Fieschi; A Carpi
Journal:  J R Soc Med       Date:  1987-02       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.